Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash from Operations (2016 - 2025)

Marimed (MRMD) has disclosed Cash from Operations for 13 consecutive years, with 3429000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 930.27% to 3429000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7695000.0 through Dec 2025, up 13.41% year-over-year, with the annual reading at 7695000.0 for FY2025, 13.41% up from the prior year.
  • Cash from Operations for Q4 2025 was 3429000.0 at Marimed, up from 2676000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 10833000.0 in Q2 2021, with the low at 6261000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 3277800.0, with a median of 3197500.0 recorded in 2024.
  • The sharpest move saw Cash from Operations surged 1760.26% in 2021, then tumbled 157.8% in 2022.
  • Over 5 years, Cash from Operations stood at 7607000.0 in 2021, then tumbled by 77.17% to 1737000.0 in 2022, then soared by 86.18% to 3234000.0 in 2023, then tumbled by 112.77% to 413000.0 in 2024, then soared by 930.27% to 3429000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 3429000.0, 2676000.0, and 297000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.